Christopher Cabell

Christopher Cabell

Vermogen: 1 M $ op 31-10-2026

57 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Christopher H.
Cabell
is Chief Executive Officer at CorHepta Pharmaceuticals, Inc. since 2024.
Director at ScienceMedia, Inc. since 2020.
Independent Director at Pulmatrix, Inc. since 2020.
Member at American College of Cardiology Foundation.
President & Head-Research & Development at Inhibikase Therapeutics, Inc. starting 2025.
Formerly Chief Medical Officer & Executive Vice President at Zura Bio Ltd. from 2023 to 2024.
Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. from 2021 to 2023.
Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. in 2020.
Senior VP & Head-Therapeutic Delivery Unit at Quintiles Transnational Corp.
from 2015 to 2017.
Chief Medical & Scientific Officer at Quintiles, Inc. (California), IQVIA RDS, Inc., and IQVIA, Inc. from 2007 to 2017.
Director at Cenduit LLC.
Director-Echocardiography Core Lab at Duke Clinical Research Institute.
Co-Chairman at US Food & Drug Administration and Cardiac Safety Research Consortium.
Associate Professor at Duke University School of Medicine.
Education includes graduate degree from Duke University, undergraduate degree from The Pennsylvania State University, and doctorate from Duke University School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-04-2026 676.564 ( 0,48% ) 1 M $ 31-10-2026
28-08-2026 0 ( -.--% ) - $ 31-10-2026

Actieve functies van Christopher Cabell

BedrijvenFunctieBegin
INHIBIKASE THERAPEUTICS, INC. President 21-02-2025
PULMATRIX, INC. Directeur/Bestuurslid 23-06-2020
Directeur/Bestuurslid 18-02-2020
Corporate Officer/Principal 30-04-2009

Eerdere bekende functies van Christopher Cabell

BedrijvenFunctieEinde
ZURA BIO LIMITED Hoofd Techniek/Wetenschap/O&O 15-01-2024
EMERGENT BIOSOLUTIONS INC. Hoofd Techniek/Wetenschap/O&O 01-01-2023
ARENA PHARMACEUTICALS Hoofd Techniek/Wetenschap/O&O 01-12-2020
Hoofd Techniek/Wetenschap/O&O 01-09-2017
Hoofd Techniek/Wetenschap/O&O 22-07-2011
Ervaring van Christopher Cabell in detail bekijken

Opleiding van Christopher Cabell

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

68

Eerstegraads connecties

18

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit18

Commercial Services

Technology Services

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Government

Health Services

Commercial Services

Technology Services

Distribution Services

Health Technology

Consumer Services

Health Technology

Cardiac Safety Research Consortium

Health Technology

  1. Beurs
  2. Insiders
  3. Christopher Cabell